
|Articles|April 28, 2023
Trends in Bio/Pharma Facilities: Ken Gilmartin Gives His Perspective (INTERPHEX 2023)
Wood CEO Ken Gilmartin gives his insight on what's currently in demand in terms of new bio/pharma manufacturing facilities.
Advertisement
Ken Gilmartin, CEO, Wood, gives his insight on what's currently in demand in terms of new bio/pharma manufacturing facilities. He emphasizes that a significant amount of capital is being invested in the United States for facilities, particularly in the large molecule and cell and gene therapy sectors.
For more INTERPHEX 2023 video content, check
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
2
From AI to Smart Factories: How Pharma Is Preparing for 2026
3
Amgen Acquires UK Biotech Dark Blue Therapeutics
4
FUJIFILM Irvine Scientific Becomes FUJIFILM Biosciences
5



